These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 33100200)
21. Danzhi Qing'e (DZQE) activates AMPK pathway and regulates lipid metabolism in a rat model of perimenopausal hyperlipidaemia. Xing X; Su L; Asare PF; Wang L; Li L; Liu E; Yu B; Zhu Y; Gao X; Fan G Exp Physiol; 2016 Nov; 101(11):1406-1417. PubMed ID: 27456335 [TBL] [Abstract][Full Text] [Related]
22. Sex steroids and bone density in premenopausal and perimenopausal women. Steinberg KK; Freni-Titulaer LW; DePuey EG; Miller DT; Sgoutas DS; Coralli CH; Phillips DL; Rogers TN; Clark RV J Clin Endocrinol Metab; 1989 Sep; 69(3):533-9. PubMed ID: 2527242 [TBL] [Abstract][Full Text] [Related]
23. Temporal relationships between ovulation and defined changes in the concentration of plasma estradiol-17 beta, luteinizing hormone, follicle-stimulating hormone, and progesterone. I. Probit analysis. World Health Organization, Task Force on Methods for the Determination of the Fertile Period, Special Programme of Research, Development and Research Training in Human Reproduction. Am J Obstet Gynecol; 1980 Oct; 138(4):383-90. PubMed ID: 6775535 [TBL] [Abstract][Full Text] [Related]
24. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels. Reyes FI; Winter JS; Faiman C Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845 [TBL] [Abstract][Full Text] [Related]
25. [Hormonal phenomena of the perimenopause]. Netter A Contracept Fertil Sex (Paris); 1979 Nov; 7(11):815-6. PubMed ID: 12261682 [TBL] [Abstract][Full Text] [Related]
26. Association of menopausal vasomotor symptoms with increased bone turnover during the menopausal transition. Crandall CJ; Tseng CH; Crawford SL; Thurston RC; Gold EB; Johnston JM; Greendale GA J Bone Miner Res; 2011 Apr; 26(4):840-9. PubMed ID: 20878774 [TBL] [Abstract][Full Text] [Related]
27. Prevalence of metabolic syndrome in Gwalior region of Central India: A comparative study using NCEP ATP III, IDF and Harmonized criteria. Subramani SK; Mahajan S; Chauhan P; Yadav D; Mishra M; Pakkirisamy U; Prasad GBKS Diabetes Metab Syndr; 2019; 13(1):816-821. PubMed ID: 30641814 [TBL] [Abstract][Full Text] [Related]
28. Follicle-stimulating hormone and oestradiol levels during perimenopause in a cohort of Japanese women. Yamada M; Soda M; Fujiwara S Int J Clin Pract; 2008 Oct; 62(10):1623-7. PubMed ID: 18673398 [TBL] [Abstract][Full Text] [Related]
29. Bone turnover alterations across the menopausal transition in south-eastern Chinese women [corrected]. Ma L; Song Y; Li C; Wang E; Zheng D; Qu F; Zhou J Climacteric; 2016 Aug; 19(4):400-5. PubMed ID: 27147201 [TBL] [Abstract][Full Text] [Related]
30. The prevalence of metabolic syndrome in premenopausal and postmenopausal women in Southern Thailand. Jeenduang N; Trongsakul R; Inhongsa P; Chaidach P Gynecol Endocrinol; 2014 Aug; 30(8):573-6. PubMed ID: 24720345 [TBL] [Abstract][Full Text] [Related]
31. Biopsychosocial predictors of depressive symptoms in the perimenopause-findings from the Swiss Perimenopause Study. Willi J; Süss H; Grub J; Ehlert U Menopause; 2021 Jan; 28(3):247-254. PubMed ID: 33399325 [TBL] [Abstract][Full Text] [Related]
32. Relationship between plasma calcium fractions, other bone-related variables, and serum follicle-stimulating hormone levels in premenopausal, perimenopausal, and postmenopausal women. Nordin BE; Morris HA; Need AG; Horowitz M; Robertson WG Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 1):140-5. PubMed ID: 2375337 [TBL] [Abstract][Full Text] [Related]
33. Association between metabolic syndrome and chronic kidney disease in perimenopausal women. Li Y; Zhao L; Chen Y; Liu A; Liu X; Shao X; Zhang Y; Wang H; Wang X; Li B; Deng K; Liu Q; Holthöfer H; Zou H Int J Environ Res Public Health; 2013 Aug; 10(9):3987-97. PubMed ID: 23999547 [TBL] [Abstract][Full Text] [Related]
34. Risk prediction model of metabolic syndrome in perimenopausal women based on machine learning. Xiaoxue W; Zijun W; Shichen C; Mukun Y; Yi C; Linqing M; Wenpei B Int J Med Inform; 2024 Aug; 188():105480. PubMed ID: 38754284 [TBL] [Abstract][Full Text] [Related]
35. Neck Circumference and Cardio-Metabolic Risk in Normal Exercise Capacity Perimenopausal/Menopausal Women. Tongdee P; Nimkuntod P J Med Assoc Thai; 2016 Oct; 99 Suppl 7():S55-61. PubMed ID: 29901923 [TBL] [Abstract][Full Text] [Related]
36. Adverse Effects of Selected Markers on the Metabolic and Endocrine Profiles of Obese Women With and Without PCOS. Daghestani MH; Daghestani MH; Warsy A; El-Ansary A; Omair MA; Omair MA; Hassen LM; Alhumaidhi EM; Al Qahtani B; Harrath AH Front Endocrinol (Lausanne); 2021; 12():665446. PubMed ID: 34122339 [TBL] [Abstract][Full Text] [Related]
37. Reproductive Hormones and Anthropometry: A Follow-Up of PCOS and Controls From Perimenopause to Older Than 80 Years. Forslund M; Schmidt J; Brännström M; Landin-Wilhelmsen K; Dahlgren E J Clin Endocrinol Metab; 2021 Jan; 106(2):421-430. PubMed ID: 33205205 [TBL] [Abstract][Full Text] [Related]
38. Follicle stimulating hormone, its association with glucose and lipid metabolism during the menopausal transition. Wang X; Zhang H; Chen Y; Du Y; Jin X; Zhang Z J Obstet Gynaecol Res; 2020 Aug; 46(8):1419-1424. PubMed ID: 32510824 [TBL] [Abstract][Full Text] [Related]
39. Effect of acupoint catgut-embedding on the quality of life, reproductive endocrine and bone metabolism of postmenopausal women. Chen GZ; Xu YX; Zhang JW; Liu SH; Guo ZY Chin J Integr Med; 2010 Dec; 16(6):498-503. PubMed ID: 21110174 [TBL] [Abstract][Full Text] [Related]
40. Correlation between sonographic and endocrine markers of ovarian aging as predictors for late menopausal transition. Yang YS; Hur MH; Kim SY; Young K Menopause; 2011 Feb; 18(2):138-45. PubMed ID: 21341396 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]